US FDA Approves 30-Minute Onset Of Action For Focalin(R) XR, Bringing Potential Benefits To ADHD Patients During Early ... (Medical News Today)
The US Food and Drug Administration (FDA) has approved a 30-minute onset of action for Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), bringing potential benefits for young patients and their families during the important morning period when they are preparing for school.

Gravy or Turkey From the FDA? (The Motley Fool)
These drugmakers should be made aware of their fate over the next few weeks.

HHS And FDA Chiefs To Travel To China To Further Improve Cooperation On Food Safety (Medical News Today)
HHS Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach, M.D., will travel to the People's Republic of China during the week of Nov. 17, 2008, for consultations with their Chinese counterparts. During this week, as part of an ongoing strategy to address the food safety issues in both countries and to share ideas to address global food safety, U.S.